VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Bridging the gap between basic & clinical research to achieve personalized therapy in myeloma

Francesco Maura, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, talks on the importance of integrating advances in basic research into clinical trials for multiple myeloma and combining novel technologies together in order to provide personalized therapies to patients. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter